Abstract

Get full access to this article
View all access options for this article.
References
1.
Pajoumand
M
Erstad
BL
Camamo
JM.
Use of epoetin alfa in critically ill patients . Ann Pharmacother 2004 ;38 :641 –8 . DOI 10.1345/aph.1D368.
2.
Vincent
JL
Baron
JF
Reinhart
K
Gattinoni
L
Thijs
L
Webb
A
Anemia and blood transfusion in critically ill patients . JAMA 2002 ;288 :1499 –507 .
3.
Darveau
M
Notebaert
E
Denault
AY
Bélisle
S.
Recombinant human erythropoietin use in intensive care . Ann Pharmacother 2002 ;36 :1068 –74 . DOI 10.1345/aph.1A323.
4.
Corwin
HL
Gettinger
A
Pearl
RG
Fink
MP
Levy
MM
Shapiro
MJ
Efficacy of recombinant human erythropoietin in critically ill patients . JAMA 2002 ;288 :2827 –35 .
5.
Carson
JL.
Should patients in intensive care units receive erythropoietin? JAMA 2002 ;288 :2884 –6 .
6.
Hébert
PC
Wells
G
Blajchman
MA
Marshall
J
Martin
C
Pagliarello
G
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care . N Engl J Med 1999 ;340 :409 –17 .
